Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group - Concepedia

Concepedia

Publication | Closed Access

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

82

Citations

25

References

2015

Year

Anna Patrikidou, Julien Dômont, Sylvie Chabaud, Isabelle Ray‐Coquard, J.M. Coindre, B. Bui-Nguyen, Antoine Adenis, María Rios, François Bertucci, Florence Duffaud,

European Journal of Cancer

Gist PatientsMedicineMetronomic TherapyPathologyMolecular SubgroupsCancer TreatmentOncologyRadiation OncologyCancer ResearchBfr14 Trial

References

	Year	Citations

Page 1

Page 1